Future Table of Contents


Future Table of Contents

Volume 26, Number 5 (October 2019)

Based on the author provided metadata and may not accurately reflect the final Table of Contents

Medullary Thyroid Introduction
M. K. Gupta

Does the frequency of routine follow-up after curative treatment for head and neck cancer impact survival?
S. Hall

Cost-effectiveness analysis of selective first line use of biologics for wild-type RAS unresectable left-sided metastatic colorectal cancer
W. WL. Wong

Cost-utility analysis of 21-gene assay for node-positive, early breast cancer
L. Masucci, S. Torres, A. Eisen, M. E. Trudeau, I. Tyono, H. Saunders, K. Kar-Wing Chan, W. Isaranuwatchai

Descriptive Analysis of Dosing and Outcomes of Ibrutinib-treated Relapsed Refractory CLL Patients in a Canadian Centre
K. Uminski, K. Brown, O. Bucher, I. Hibbert, D. H. Dhaliwal, J. B. Johnston, M. Geirnaert, D. Dawe, V. Banerji

Ontario-wide Cancer Targeted Nucleic Acid Evaluation (OCTANE): A platform for intra-provincial, national and international clinical data sharing
E. R. Malone, R. Saleh, C. Yu, L. Ahmed, T. Pugh, J. Torchia, J. Bartlett, C. Virtanen, S. Hotte, J. Hilton, S. Welch, A. Robinson, E. McCready, B. Lo, B. Sadikovic, H. Feilotter, T. Hanna, S. Kamel-Reid, T. Stockley, L. Siu, P. Bedard

A Retrospective Observational Study to Estimate the Attrition of Patients Across Lines of Systemic Treatment for Metastatic Colorectal Cancer in Canada
H. Kennecke, S. Berry, J. Maroun, P. Kavan, N. Aucoin, F. Couture, B. Gillesby

Cross Canada differences in early stage breast cancer treatment and acute care utilization
M. Powis, P. Groome, N. Biswanger, C. Kendell, K. M. Decker, E. Grunfeld, M. L. McBride, R. Urquhart, M. Winget, G. A. Porter, M. K. Krzyzanowska

Real-world Use of Trifluridine/Tipiracil (FTD/TPI) for Patients with Metastatic Colorectal Cancer (mCRC) in Canada
H. Samawi

Radiotherapy Intensification Using Novel Androgen Receptor Inhibitors for Prostate Cancer
M. Ghashghaei, M. kucharczyk, S. Elakshar, T. Muanza, T. Niazi

Melanoma nodal management in Ontario following the 20012 ASCO/SSO Guidelines
S. Latosinsky, B. Allen, S. Z. Shariff

Implementing a one-day testing model improves timeliness of work-up for lung cancer patients
D. E. Maziak

Diagnosis and Pathologic Characteristics of Medullary Thyroid Carcinoma - Review of Current Guidelines
C. M. Thomas, S. L. Asa, S. Ezzat, A. M Sawka, D. Goldstein

Clinical Practice Guidelines for Image-guidance Multi-mode Tumor Ablation Therapy System of Hepatic Malignant Tumor
G. Wang, X. He, Y. Wang, L. Xu, H. Huang, Y. Wang, W. Li

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2018
J. A. Chaters

The generation of two specific cancer costing algorithms using Ontario administrative databases
N. Mittmann

Honorary authorship in prominent medical oncology clinical trials
Dan Y. Gui, Glen J. Weiss

Complete resolution of chylopericardium following chemotherapy for chronic lymphocytic leukemia
A. L. Morris

Panitumumab-Induced Pulmonary Toxicity: Case Report
R. Arora, M. Kisiel, C. MacColl

Gemcitabine Induced Pseudocellulitis: A case report and review of the literature
H. Bami

Primary Yolk Sac Tumor of the Prostate Mimicking Small Round Blue Cell Tumor
H. Gui

Upcoming in Current Oncology

Countercurrents: The Bias of Choice
Steven Alexander Narod

Evaluation of an Interlaboratory Proficiency Testing Scheme for Tumor Next-generation Sequencing in Ontario
T. L. Stockley

The SOmatic Curation and Interpretation Across Laboratories (SOCIAL) Project – Current State of Solid Tumor Variant Interpretation for Molecular Pathology in Canada
T. L. Stockley

Combined cancer patient reported symptom and health utility tool for routine clinical implementation: A real world comparison of ESAS and EQ5D across multiple cancer sites
M. Moskovitz, J. Kevin, J. Su, H. Naik, M. L. Eng, C. Brown, T. Wang, H. Naik, J. Kuo, Y, Leung, Wei Xu, N. Mittmann, L. Moody, L. Barbera, G. Devins, M. Li, D. Howell, G. Liu

Implementation of a Comprehensive Smoking Cessation Program in Cancer Care
N. Abdelmutti, J. Brual, J. Papadakos, S. Fathima, J. Jones, D. Goldstein, L. Eng, T. Papadakos, G. Liu, M. E. Giuliani

Patient-physician discordance in goals of care for patients with advanced cancer
S. L. Douglas, B. J. Daly, N. J. Meropol, A. R. Lipson

Radiotherapy Versus Surgery Alone in the Treatment of Retroperitoneal Sarcoma: A Population-Based Comparison
B. Turner, L. Hampton, L. Mack, D. Schiller, C. Robertson-More, H. Li, M. Quan, A. Bouchard-Fortier

Impact of gut microbiome on immune checkpoint inhibitors efficacity. A systematic review
J. Pierrard

A Primer on the Genetics of Medullary Thyroid Cancer
V. Larouche, A. Akirov, C. M. Thomas, M. K. Krzyzanowska, S. Ezzat

Report from the 20th Annual Western Canadian Gastrointestinal Cancer Consensus Conference. Saskatoon, Saskatchewan; September 28–29th, 2018
D. Le